A capital raise of $0.84 million (before costs) demonstrates growing confidence in the Felix sperm separation device, according to ASX-listed reproductive biotechnology company Memphasys. According to a statement from the company on Monday, it has successfully completed a share placement for that amount, with an additional non-renounceable rights issue to eligible shareholders potentially raising up…
Reproductive technology company Memphasys came out of a trading halt on Monday morning, telling investors that it has received binding commitments to raise $1.275 million through a strategic placement. In a statement to the ASX, Memphasys said the commitments were from new and existing shareholders, amounting to 212,500,000 ordinary shares at $0.006 per share. Participants…
HEO shares progress on Holmes Mk2 space camera Space business HEO has shared that work is well underway for its first Holmes Mk2 flight model camera, with the team undertaking “the finishing touches and prepar[ing] for the final phase of testing. In an update on Linkedin, HEO said its smallest non-Earth imaging camera, “provides a…
Memphasys claims defining milestone for Felix Reproductive technology company Memphasys has announced the successful data from a “pivotal clinical trial” for the Felix System, “confirming its best-in-class performance in sperm selection for Assisted Reproductive Technology (ART).” Conducted in partnership through Monash IVF, Memphasys said on Monday that the trial results show Felix as “non-inferior to…
Tariff exemption consideration a welcome first step: Ai Group The agreement by US president Donald Trump to consider an exemption for Australian steel, aluminium and iron from a 25 per cent tariff is “a welcome first step to protect vital industries with more than 100,000 mostly regional jobs,” Innes Willox, Chief Executive of the Australian…
ARE receives $5m grant for rare earths development Australian Rare Earths has received a $5 million grant from the federal government’s International Partnerships in Critical Minerals Program. The funding will support additional metallurgical test work, completion of a pre-feasibility study and building/operating a demonstration plant at the company’s Koppamurra project, a frontier ionic clay rare…
Codan completes the acquisition of Kägwerks Communications and metal detection manufacturer Codan, through its wholly owned subsidiary, Codan US Inc, has completed the acquisition of 100 percent of US-based organisation SKT2 LLC dba Kägwerks (Kägwerks). Kägwerks is a leader in tactical operator-worn networking communications technologies that enable connectivity and integrated secure networking in a military…
Optiscan Imaging advances veterinary medtech Confocal microscopy manufacturer Optiscan Imaging has signed a Collaborative Research Agreement with the University of Minnesota College of Veterinary Medicine. The agreement follows a MOU with the university, and is a step in expanding the clinical applications of Optiscan’s confocal endomicroscope imaging system in veterinary medicine. The initial focus of…
Clinical trials of its Felix sperm separation device for IVF clinics are now 90 per cent complete, according to reproductive technology specialist Memphasys, with the company also sharing that it now anticipates “entering larger markets earlier than previously expected” following a decision to pursue CE mark registration. In a statement on Thursday, the company told…
Memphasys commits to equine fertility study Reproductive technology company Memphasys has committed to a three-year equine fertility study, aimed at positioning its Felix laboratory instrument for sperm separation as a leading solution for the equine reproduction sector. The company expects commercial outcomes within 12 months from the trial, to be conducted in conjunction with the…